切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (04) : 363 -366. doi: 10.3877/cma.j.issn.1674-3946.2024.04.003

专家论坛

腹腔镜解剖性肝切除的发展
陆朝阳1,(), 金也1, 孙备1   
  1. 1. 150001 哈尔滨,哈尔滨医科大学附属第一医院肝脏外科,肝脾外科教育部重点实验室
  • 收稿日期:2023-11-30 出版日期:2024-08-26
  • 通信作者: 陆朝阳

The development and prospect of laparoscopic anatomic hepatectomy

Zhaoyang Lu1,(), Ye Jin1, Bei Sun1   

  1. 1. Department of Hepatic Surgery, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, the First Affiliated Hospital of Harbin Medical University, Harbin Heilongjiang Province 150001, China
  • Received:2023-11-30 Published:2024-08-26
  • Corresponding author: Zhaoyang Lu
  • Supported by:
    National Natural Science Foundation of China(81972230)
引用本文:

陆朝阳, 金也, 孙备. 腹腔镜解剖性肝切除的发展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 363-366.

Zhaoyang Lu, Ye Jin, Bei Sun. The development and prospect of laparoscopic anatomic hepatectomy[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(04): 363-366.

解剖性肝切除是指完整切除荷瘤门静脉流域内的肝实质,在其理论与技术操作不断完善、丰富的过程中,对于其实际疗效的质疑与争议从未停歇。先进技术的应用与普及促进肝脏外科迎来新的发展机遇,也为充实并丰富解剖性肝切除理论创造新的契机,有望更好实现肝细胞癌的治疗效果。

Anatomic hepatectomy aims to the complete removal of liver parenchyma within the portal vein. In the process of improvement and enrichment of its theory and technology, there has never been cessation of doubts and controversies. The application and popularization of advanced technology promote new development opportunities in liver surgery, and also create new opportunities to enrich the theory of anatomic hepatectomy, which is expected to better achieve the treatment effect of hepatocellular carcinoma.

[1]
陈琳,陈孝平. 不断推动中国肝癌临床诊治规范化[J/CD].中华普外科手术学杂志(电子版)2022, 16(06), 591-594.
[2]
刘连新,刘光. 中国腹腔镜肝癌手术需要规范几个问题[J/CD].中华普外科手术学杂志(电子版)2022, 16(06), 594-598.
[3]
贾昌俊,戴朝六. 中国腹腔镜肝癌手术式选择与规范化[J/CD].中华普外科手术学杂志(电子版)2022, 16(06), 598-602.
[4]
Couinaud C,Le foie. Etudes Anatomiques et Chirurgicales[M]. Paris: Masson,1957.
[5]
Makuuchi MHasegawa HYamazaki S. Ultrasonically guided subsegmentectomy[J]. Surg Gynecol Obstet1985, 161(4):346-350.
[6]
Shindoh JMakuuchi MMatsuyama Y,et al. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma[J]. J Hepatol2016,64(3):594-600.
[7]
Hasegawa KKokudo NImamura H,et al.Prognostic impact of anatomic resection for hepatocellular carcinoma[J]. Ann Surg2005, 242(2): 252-259.
[8]
Hokuto DNomi TYasuda S,et al. Does anatomic resection improve the postoperative outcomes of solitary hepatocellular carcinomas located on the liver surface[J]. Surgery2018, 163(2): 285-290.
[9]
Cho JYHan HSChoi Y,et al. Association of Remnant Liver Ischemia With Early Recurrence and Poor Survival After Liver Resection in Patients With Hepatocellular Carcinoma[J]. JAMA Surg2017, 152(4):386-392.
[10]
Moris DTsilimigras DIKostakis ID,et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis[J].Eur J Surg Oncol2018, 44(7): 927-938.
[11]
Moris DTsilimigras DIKostakis ID,et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis[J].Eur J Surg Oncol2018, 44(7): 927-938.
[12]
Li SQHuang TShen SL,et al. Anatomical versus non-ana- tomical liver resection for hepatocellular carcinoma exceeding Milan criteria[J]. Br J Surg2017,104(1):118-127.
[13]
Ju MYopp AC. The utility of anatomical liver resection in hepatocellular carcinoma: associated with improved outcomes or lack of supportive evidence?[J]. Cancers(Basel)2019. 11(10):1441.
[14]
Marubashi SGotoh KAkita H,et al. Anatomical versus non-anatomical resection for hepatocellular carcinoma[J]. Br J Surg2015,102(7):776-784.
[15]
Viganò LProcopio FMimmo A,et al. Oncologic superiority of anatomic resection of hepatocellular carcinoma by ultrasound-guided compression of the portal tributaries compared with nonanatomic resection: an analysis of patients matched for tumor characteristics and liver function[J]. Surgery2018, 164(5):1006-1013.
[16]
Moris DTsilimigras DIKostakis ID,et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta -analysis[J]. Eur J Surg Oncol2018, 44(7):927-938.
[17]
Wu JYSun JXBai YN,et al. Long-term outcomes of anatomic versus nonanatomic resection in hepatocellular carcinoma patients with bile duct tumor thrombus: a propensity score matching analysis[J]. Ann Surg Oncol2021, 28(12):7686-7695.
[18]
Hidaka MEguchi SOkuda K,et al. Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1): a multi-institutional study by the kyushu study group of liver surgery[J]. Ann Surg2020, 271(2):339-346.
[19]
Dip FLoMenzo ESarotto L,et al. Randomized trial of near-infrared incisionless fluorescent cholangiography[J]. Ann Surg2019, 270:992.
[20]
Xiang LXiao LLi J,et al. Safety and feasibility of laparoscopic hepatectomy for hepatocellular carcinoma in the posterosuperior liver segments[J]. World J Surg2015, 39:1202-1209.
[21]
Terasawa MIshizawa TMise Y,et al. Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy[J]. Surg Endosc2017, 31:5111-5118.
[1] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[7] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[8] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[9] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[10] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[11] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[12] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[15] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?